BioCentury
ARTICLE | Clinical News

Vestar Inc. regulatory update

June 21, 1993 7:00 AM UTC

Vestar Inc. (VSTR) Vestar Inc. (VSTR) said that AmBisome, its intravenous liposomal formulation of amphotericin B, received marketing approval in Greece as a treatment for systemic fungal infections...